← Open Payments lookup

NAVEEN MISHRA: Open Payments

NPI 1336247733 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$847 in 34 payments from 9 companies in 2025. Trend: 2023 $620 · 2024 $806 · 2025 $847

Food & beverage: $735Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.5$185
E.R. Squibb & Sons, L.L.C.5$150
Janssen Pharmaceuticals, Inc5$123
ABBVIE INC.6$116
Alkermes, Inc.4$98
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
Otsuka America Pharmaceutical, Inc.3$54
Neurocrine BioSciences, Inc.2$40
Luye Pharma (USA) Ltd.1$18

Products named: COBENFY, INVEGA SUSTENNA, VRAYLAR, ARISTADA, CAPLYTA, REXULTI, AUSTEDO XR, INGREZZA.

Industry payments across CA — which companies pay providers there.